Pilot study of outpatient paclitaxel, carboplatin and gemcitabine for advanced stage epithelial ovarian, peritoneal, and fallopian tube cancer

Cancer Statistics, 2001

Robert T. Greenlee, M. B. Hill-Harmon, Thomas S. Murray et al. · CA A Cancer Journal for Clinicians · 2001 · 3.3K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Carboplatin dosage: prospective evaluation of a simple formula based on renal function.

A. Hilary Calvert, David R. Newell, Lindsey Gumbrell et al. · Journal of Clinical Oncology · 1989 · 1.9K citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial

The Lancet · 2002 · 560 citations

Medicine, Gynecology, Oncology +11

Creatinine Clearance: Bedside Estimate

Roger W. Jelliffe · Annals of Internal Medicine · 1973 · 494 citations

Pharmacy, Clinical Pharmacokinetics, Nephrology +17

Phase II Study of Gemcitabine (2',2'-Difluorodeoxycytidine) in Previously Treated Ovarian Cancer Patients

Birthe Lund, Ole Hansen, Karen Theilade et al. · JNCI Journal of the National Cancer Institute · 1994 · 346 citations

Medicine, Oncology, Pharmacology +17